schliessen

Filtern

 

Bibliotheken

Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis

To conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes. We searched MEDLINE and EMBASE databases through August 2015. We conducted a qualitative review o... Full description

Journal Title: Diabetes care May 2016, Vol.39(5), pp.833-46
Main Author: Guasch-Ferré, Marta
Other Authors: Hruby, Adela , Toledo, Estefanía , Clish, Clary B , Martínez-González, Miguel A , Salas-Salvadó, Jordi , Hu, Frank B
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1935-5548 ; PMID: 27208380 Version:1 ; DOI: 10.2337/dc15-2251
Link: http://pubmed.gov/27208380
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline27208380
title: Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
format: Article
creator:
  • Guasch-Ferré, Marta
  • Hruby, Adela
  • Toledo, Estefanía
  • Clish, Clary B
  • Martínez-González, Miguel A
  • Salas-Salvadó, Jordi
  • Hu, Frank B
subjects:
  • Diabetes Mellitus, Type 2 -- Metabolism
  • Metabolomics -- Methods
  • Prediabetic State -- Metabolism
ispartof: Diabetes care, May 2016, Vol.39(5), pp.833-46
description: To conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes. We searched MEDLINE and EMBASE databases through August 2015. We conducted a qualitative review of cross-sectional and prospective studies. Additionally, meta-analyses of metabolite markers, with data estimates from at least three prospective studies, and type 2 diabetes risk were conducted, and multivariable-adjusted relative risks of type 2 diabetes were calculated per study-specific SD difference in a given metabolite. We identified 27 cross-sectional and 19 prospective publications reporting associations of metabolites and prediabetes and/or type 2 diabetes. Carbohydrate (glucose and fructose), lipid (phospholipids, sphingomyelins, and triglycerides), and amino acid (branched-chain amino acids, aromatic amino acids, glycine, and glutamine) metabolites were higher in individuals with type 2 diabetes compared with control subjects. Prospective studies provided evidence that blood concentrations of several metabolites, including hexoses, branched-chain amino acids, aromatic amino acids, phospholipids, and triglycerides, were associated with the incidence of prediabetes and type 2 diabetes. We meta-analyzed results from eight prospective studies that reported risk estimates for metabolites and type 2 diabetes, including 8,000 individuals of whom 1,940 had type 2 diabetes. We found 36% higher risk of type 2 diabetes per study-specific SD difference for isoleucine (pooled relative risk 1.36 [1.24-1.48]; I(2) = 9.5%), 36% for leucine (1.36 [1.17-1.58]; I(2) = 37.4%), 35% for valine (1.35 [1.19-1.53]; I(2) = 45.8%), 36% for tyrosine (1.36 [1.19-1.55]; I(2) = 51.6%), and 26% for phenylalanine (1.26 [1.10-1.44]; I(2) = 56%). Glycine and glutamine were inversely associated with type 2 diabetes risk (0.89 [0.81-0.96] and 0.85 [0.82-0.89], respectively; both I(2) = 0.0%). In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
language: eng
source:
identifier: E-ISSN: 1935-5548 ; PMID: 27208380 Version:1 ; DOI: 10.2337/dc15-2251
fulltext: fulltext
issn:
  • 19355548
  • 1935-5548
url: Link


@attributes
ID735088423
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid27208380
sourceidmedline
recordidTN_medline27208380
sourceformatXML
sourcesystemOther
pqid1790466462
galeid452625550
display
typearticle
titleMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
creatorGuasch-Ferré, Marta ; Hruby, Adela ; Toledo, Estefanía ; Clish, Clary B ; Martínez-González, Miguel A ; Salas-Salvadó, Jordi ; Hu, Frank B
ispartofDiabetes care, May 2016, Vol.39(5), pp.833-46
identifier
subjectDiabetes Mellitus, Type 2 -- Metabolism ; Metabolomics -- Methods ; Prediabetic State -- Metabolism
descriptionTo conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes. We searched MEDLINE and EMBASE databases through August 2015. We conducted a qualitative review of cross-sectional and prospective studies. Additionally, meta-analyses of metabolite markers, with data estimates from at least three prospective studies, and type 2 diabetes risk were conducted, and multivariable-adjusted relative risks of type 2 diabetes were calculated per study-specific SD difference in a given metabolite. We identified 27 cross-sectional and 19 prospective publications reporting associations of metabolites and prediabetes and/or type 2 diabetes. Carbohydrate (glucose and fructose), lipid (phospholipids, sphingomyelins, and triglycerides), and amino acid (branched-chain amino acids, aromatic amino acids, glycine, and glutamine) metabolites were higher in individuals with type 2 diabetes compared with control subjects. Prospective studies provided evidence that blood concentrations of several metabolites, including hexoses, branched-chain amino acids, aromatic amino acids, phospholipids, and triglycerides, were associated with the incidence of prediabetes and type 2 diabetes. We meta-analyzed results from eight prospective studies that reported risk estimates for metabolites and type 2 diabetes, including 8,000 individuals of whom 1,940 had type 2 diabetes. We found 36% higher risk of type 2 diabetes per study-specific SD difference for isoleucine (pooled relative risk 1.36 [1.24-1.48]; I(2) = 9.5%), 36% for leucine (1.36 [1.17-1.58]; I(2) = 37.4%), 35% for valine (1.35 [1.19-1.53]; I(2) = 45.8%), 36% for tyrosine (1.36 [1.19-1.55]; I(2) = 51.6%), and 26% for phenylalanine (1.26 [1.10-1.44]; I(2) = 56%). Glycine and glutamine were inversely associated with type 2 diabetes risk (0.89 [0.81-0.96] and 0.85 [0.82-0.89], respectively; both I(2) = 0.0%). In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
languageeng
source
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/27208380$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontrib
0Guasch-Ferré, Marta
1Hruby, Adela
2Toledo, Estefanía
3Clish, Clary B
4Martínez-González, Miguel A
5Salas-Salvadó, Jordi
6Hu, Frank B
titleMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
description
0To conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes.
1We searched MEDLINE and EMBASE databases through August 2015. We conducted a qualitative review of cross-sectional and prospective studies. Additionally, meta-analyses of metabolite markers, with data estimates from at least three prospective studies, and type 2 diabetes risk were conducted, and multivariable-adjusted relative risks of type 2 diabetes were calculated per study-specific SD difference in a given metabolite.
2We identified 27 cross-sectional and 19 prospective publications reporting associations of metabolites and prediabetes and/or type 2 diabetes. Carbohydrate (glucose and fructose), lipid (phospholipids, sphingomyelins, and triglycerides), and amino acid (branched-chain amino acids, aromatic amino acids, glycine, and glutamine) metabolites were higher in individuals with type 2 diabetes compared with control subjects. Prospective studies provided evidence that blood concentrations of several metabolites, including hexoses, branched-chain amino acids, aromatic amino acids, phospholipids, and triglycerides, were associated with the incidence of prediabetes and type 2 diabetes. We meta-analyzed results from eight prospective studies that reported risk estimates for metabolites and type 2 diabetes, including 8,000 individuals of whom 1,940 had type 2 diabetes. We found 36% higher risk of type 2 diabetes per study-specific SD difference for isoleucine (pooled relative risk 1.36 [1.24-1.48]; I(2) = 9.5%), 36% for leucine (1.36 [1.17-1.58]; I(2) = 37.4%), 35% for valine (1.35 [1.19-1.53]; I(2) = 45.8%), 36% for tyrosine (1.36 [1.19-1.55]; I(2) = 51.6%), and 26% for phenylalanine (1.26 [1.10-1.44]; I(2) = 56%). Glycine and glutamine were inversely associated with type 2 diabetes risk (0.89 [0.81-0.96] and 0.85 [0.82-0.89], respectively; both I(2) = 0.0%).
3In studies using high-throughput metabolomics, several blood amino acids appear to be consistently associated with the risk of developing type 2 diabetes.
subject
0Diabetes Mellitus, Type 2 -- Metabolism
1Metabolomics -- Methods
2Prediabetic State -- Metabolism
general
027208380
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.2337/dc15-2251
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline27208380
issn
019355548
11935-5548
rsrctypearticle
creationdate2016
addtitleDiabetes care
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201605
citationpf 833 vol 39 issue 5
startdate20160501
enddate20160531
lsr30VSR-Enriched:[pages, issn, galeid, pqid]
sort
titleMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
authorGuasch-Ferré, Marta ; Hruby, Adela ; Toledo, Estefanía ; Clish, Clary B ; Martínez-González, Miguel A ; Salas-Salvadó, Jordi ; Hu, Frank B
creationdate20160500
lso0120160500
facets
frbrgroupid-1108477180025500944
frbrtype5
newrecords20190701
languageeng
creationdate2016
topic
0Diabetes Mellitus, Type 2–Metabolism
1Metabolomics–Methods
2Prediabetic State–Metabolism
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontrib
0Guasch-Ferré, Marta
1Hruby, Adela
2Toledo, Estefanía
3Clish, Clary B
4Martínez-González, Miguel A
5Salas-Salvadó, Jordi
6Hu, Frank B
jtitleDiabetes Care
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Guasch-Ferré
1Hruby
2Toledo
3Clish
4Martínez-González
5Salas-Salvadó
6Hu
aufirst
0Marta
1Adela
2Estefanía
3Clary B
4Miguel A
5Jordi
6Frank B
au
0Guasch-Ferré, Marta
1Hruby, Adela
2Toledo, Estefanía
3Clish, Clary B
4Martínez-González, Miguel A
5Salas-Salvadó, Jordi
6Hu, Frank B
atitleMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
jtitleDiabetes care
risdate201605
volume39
issue5
spage833
pages833-846
eissn1935-5548
formatjournal
genrearticle
ristypeJOUR
abstractTo conduct a systematic review of cross-sectional and prospective human studies evaluating metabolite markers identified using high-throughput metabolomics techniques on prediabetes and type 2 diabetes.
doi10.2337/dc15-2251
pmid27208380
issn01495992
oafree_for_read
date2016-05